Top Markets
#1 Cortex Cortex +32.71%
#2 EXOD EXOD +9.04%
#3 Seeker Seeker +8.43%
#4 ETHGas ETHGas +7.85%
#5 MarsCoin MarsCoin +7.84%
#6 peaq peaq +7.74%
#7 Official Trump Official Trump +6.67%
#8 Solstice Solstice +5.96%
#9 Ethena Staked ENA Ethena Staked ENA +5.92%
#10 DexNet DexNet +5.76%
Coin of the day
Cortex Cortex
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Pozycja w akcjach #6652
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Cena akcji
$6.02
Ostatnia synchronizacja: 2026-08-27
Kapitalizacja rynkowa
$1.93B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
112.72%
Kraj
US
Handel Taysha Gene Therapies, Inc. (TSHA)

Kategoria

Healthcare
EPS dla Taysha Gene Therapies, Inc. (TSHA)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Taysha Gene Therapies, Inc., obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Taysha Gene Therapies, Inc. od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH